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ABSTRACT
This study aimed to (1) characterize substance use treatment preferences, barriers, and
attitudes in an under-represented sample of pregnant and postpartum women; (2) examine
associations between barriers and help-seeking preferences, treatment attitudes, treatment
engagement, substance use, and well-being; and (3) examine moderating effects of culture.
Participants were 27 women, most of whom were treatment-experienced, of ethnic minority
status, and from lower-income households. Results indicated flexibility in treatment preferences,
and positive attitudes about treatment despite an extensive number of barriers. Participants
indicated greater interference from stigma, relative to instrumental barriers. Qualitative responses
revealed unique barriers experienced by this sample, and offspring well-being was most
frequently mentioned as a factor motivating treatment engagement. Aim 2 associations were not
demonstrated. However, limiting analyses to an ethnic minority subsample revealed unique
associations of acculturation and enculturation with each other and family-related treatment
barriers. Conclusions include implications for intervention and future research with this
population.
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Introduction
Maternal substance use poses significant risks to the physical health and well-being of
both mother and child, and is associated with significant distress within the family. Prenatal
substance use has been associated with poorer infant health indicators at birth including
premature birth, low infant weight, fetal alcohol spectrum syndrome, substance withdrawal
symptoms, and later problems such as delayed mental and motor development (Behnke & Eyler,
1992; Centers for Disease Control and Prevention (CDC), 2009; Coleman, Coleman, & Murray,
1990; Handmaker, Miller, & Manicke, 1999; Little et al., 1989; Nuckolls, Cassel, & Kaplan,
1972). During the postnatal months, maternal substance use has been associated with greater
risk of child abuse and neglect, loss of custody, and physical, academic, and socio-emotional
delays in the child (Conners, Bradley, Mansell, Liu, Roberts, & Burgdorf, et al., 2004; Jester et
al., 2000; McGlade, Ware, & Crawford, 2009). Additionally, problems with substance use
directly impact mothers’ physical and mental well-being, often being associated with poorer
nutrition, higher rates of depression, poorer relationship satisfaction, and increased risk of
intimate partner violence (Chapman & Wu, 2013; Fleming et al., 2008; Marshall, 2003;
Mellingen, Torsheim, & Thuen, 2013; Fleming et al., 2008; Jester et al., 2000).
Pregnancy and the time following birth represent acute periods of adjustment and place
additional mental and physical demands on the mother, rendering this a time of heightened stress
and vulnerability for some. For mothers with histories of substance use problems, their child’s
health and well-being has been cited as an instrumental motivator for abstinence during
pregnancy and reduction in use following birth (Fried et al., 1985). Nevertheless, added stressors
during pregnancy and the postpartum period also may place some women at risk for continued
use or relapse. It has been estimated that 5-20% of women continue to drink after recognizing
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they are pregnant, and approximately 2-6% of women continue to binge drink while pregnant (4
or more drinks in one sitting; CDC, 2002; 2009; Chang, 2000; Flynn et al., 2003; Jagodzinski &
Fleming, 2007; McLeod et al., 2002; Stratton et al., 1996; Ockene et al., 2002; Pirie et al., 2000).
It has been estimated that 5.4% of women have used illicit drugs such as opiates and opioids,
stimulants, cannabis, and non-prescribed prescription medication while pregnant (US
Department of Health and Human Services (USDHHS), Office of Applied Studies, 2013).
Although these are relatively small percentages, they represent large numbers of women and the
known risks render these numbers clinically significant. Furthermore, researchers caution that
the above statistics are likely underestimates given the likelihood of underreporting (USDHHS,
Office of Applied Studies, 2010).
Given the risks involved with maternal substance use, engaging this population in
treatment has been an ongoing endeavor for clinicians and researchers alike. However, women
generally are less likely than men to enter substance use treatment (Greenfield et al., 2007);
among pregnant and postpartum women who meet criteria for any psychiatric disorder, only 510% have been found to seek treatment (Andersson et al., 2003, 2006; Kelly, Russo, & Katon,
2001). Furthermore, studies have shown that women who use substances while pregnant are
likely to have fewer monetary resources, less education, histories of abuse and trauma, and less
access to healthcare (Brady, Visscher, Feder, & Burns, 2003). These factors also serve as
barriers to treatment; thus the most vulnerable members of the community are more likely to
struggle with substance use around the time of pregnancy and experience more challenges
gaining access to care. Given the continued prevalence of prenatal substance use and its impact,
efforts to improve treatment accessibility are imperative.
Treatment Barriers
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Women, and specifically mothers, face a number challenges that deter help seeking
behavior. These obstacles include a complex intertwining of instrumental, emotional, and ethnocultural factors.
Instrumental barriers. Instrumental barriers are those that involve monetary resources
or one’s physical ability to seek treatment. Particularly for mothers, these barriers include child
care needs, lack of insurance, time, transportation, and financial constraints (Caplan &
Whittemore, 2013; Dworkin et al., 2017; Goodman, 2009). Given these barriers, the
appropriateness of available treatment models has been called into question. Most extant
substance use treatments are based on individualistic, male-based recovery models and do not
cater to the specific needs of women or mothers (Copeland & Hall, 1992; Finkelstein, 1993).
Traditionally, many treatment programs require extended stays and do not offer childcare
assistance (Breibart, Chavkin, & Wise, 1994). Furthermore, many treatment options are limited
to private insurance holders and do not provide transportation assistance (Breibart, Chavkin, &
Wise, 1994). Lastly, many stand-alone mental health treatment providers will not accept
pregnant users into treatment due to liability concerns (Lester, Andreozzi, & Appiah, 2006).
Thus the availability of substance use treatment for pregnant women is both limited and at times
inaccessible for those with constrained resources.
Emotional, stigma, and cultural barriers. Emotional barriers are those that involve
mistrust in treatment providers or fear of negative repercussions as a result of treatment
engagement. One of the most prevalent and impactful emotional barriers to substance use
treatment among pregnant and postpartum mothers is fear of being separated from their children
as a result of child protective service involvement (Jessup, Humphreys, Brindis, & Lee, 2003).
Given mandatory reporting laws and the likelihood of child protective service involvement
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regardless of child placement outcomes, this often is a realistic fear with which mothers seeking
treatment have to contend.
Fear of stigmatization is another emotional barrier that has been widely studied and is of
particular concern for pregnant and postpartum mothers struggling with substance use. Vogel
and colleagues (2007) defined stigma as “a mark or flaw resulting from a personal or physical
characteristic that is viewed as socially unacceptable.” Studies demonstrate that even during
recent years the general public has espoused negative attitudes about people with identifiable
disorders or those seeking mental health care (Angermeyer & Dietrich, 2006; Crisp, Gelder, Rix,
Meltzer, & Rowlands, 2000; Vogel, Wade, & Haake, 2006). Furthermore, societal views of
substance use as a moral failing or a result of weak willpower intensify the stigma attached to
those experiencing substance use problems, resulting in more punitive and unforgiving attitudes
toward mothers (Finkelstein, 1994; Jessup & Green, 1987). Studies have indicated that public
stigma is perceived and internalized by mothers struggling with substance use, and the resulting
feelings of inadequacy as a mother, as well as guilt and shame, can discourage women from
seeking help (Jacobs, 2014). In many cases potential clients fear judgment not only from
providers, but also from their families and social circles, leaving many mothers socially isolated
in their efforts to stop or reduce substance use (Jessup et al., 2003; Mayer & Timms, 1970).
Some research indicates that the negative impacts of perceived stigma on treatment
engagement may be compounded for ethnic minority individuals. Gary (2006) proposed that
ethnic minority individuals experience “double stigma” as a result of societal marginalization
based on racial discrimination combined with marginalization due to mental illness. In partial
support of this theory, Nadeem and colleagues (2008) found that Black immigrant women were
more likely than White women to report stigma-related barriers to mental health care. However,
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differences between White and other minority participants in this study were not observed.
Although Nadeem and colleagues’ (2008) study was not specific to women with substance use
concerns, the findings may be translatable to this specific population.
It also has been proposed that ethnic minority individuals may experience compounded
threats of stigma due to specific cultural values. For instance, individuals from more
collectivistic cultural backgrounds may perceive greater threats of stigma if they believe that
exposing a mental health or substance use problem would stigmatize their family as well (Gary,
2006). Individuals from more collectivistic backgrounds also may be more influenced by the
opinions of family members and fear of negative feedback from family members may inhibit
help-seeking behaviors. As an example, Caplan and Whittemore (2013) interviewed Latina
women who met criteria for depression and experienced abuse within their families. They found
that women who attributed their depressive symptoms to their experiences of family violence did
not expect their families to be supportive and expected to be blamed for their experiences. They
cited these as reasons for not seeking help from family members or treatment programs. Caplan
and Whittemore (2013) also determined that participant responses evidenced strong values of
familismo (strong identification with, attachment to, and loyalty within one’s family) and
marianismo (feminine submissiveness and self-sacrificing generosity). Caplan and Whittemore
(2013) concluded that collectivistic cultural values, traditional gender roles, and fear of negative
responses from family members influenced participants’ choices to keep their problems to
themselves and not seek assistance. Thus, certain cultural values regarding fealty towards one’s
family may be in conflict with help-seeking behaviors when perceived threats of stigma are
present. Given that perceived stigma is a well-documented treatment barrier among many
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mothers with substance use concerns, it is possible that felt stigma due to racial discrimination or
familial repercussions may augment stigmatic effects in this population as well.
Other emotional or cultural barriers may persist as a result of communal attitudes toward
mental health care. For instance, past negative experiences with providers as a result of
discriminatory practices or language barriers may lower a community’s overall confidence in
western treatment models and in turn effect lower rates of treatment engagement. Furthermore,
in social circles where professional mental health care is used less frequently, awareness of
available services may be lacking (Diez Roux, 2012). As those with fewer monetary resources
are less likely to engage in treatment, awareness of available services may be particularly lacking
in lower income communities (Diez Roux, 2012). Thus emotional and instrumental treatment
barriers are usually overlapping, and at times compounded by ethno-cultural factors for some
individuals.
Treatment Studies
Unfortunately, treatment barriers not only impact lower income and ethnic minority
individuals’ access to care but also their representation in the treatment literature. Most studies
of substance use treatment for pre- and post-natal mothers have recruited women from obstetric
centers, thereby testing substance use treatment on samples of already treatment-engaged
individuals and women who likely have more resources at their disposal. Many of these samples
have been constituted primarily of white, middle class, English-speaking women. Despite this
limitation, studies have provided some meaningful indications for improving treatment access for
women.
Residential care. Research has indicated that meeting the gender-specific and parenting
needs of women can lead to better substance use treatment outcomes. For instance, Copeland
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and Hall (1992) compared characteristics of female patients choosing to attend a female-centered
versus a coed inpatient substance use treatment facility. Aside from gender distributions, the
treatment programs differed in specific programming content and whether children were allowed
to accompany patients in the female-centered treatment facility. The researchers found that
women choosing to enter the female-only treatment program were more likely than women in the
coed facility to have young children, to identify as lesbian, to have a mother with a history of
substance use problems, and to have been subjected to sexual abuse during childhood (Copeland
& Hall, 1992). This study indicated some significant barriers to substance use treatment,
including childcare needs and histories of trauma that might lead women to avoid coed treatment
groups and require specific treatment approaches. Copeland and Hall (1992) concluded that
programs attempting to meet gender-specific needs may reach a sector of the population that
might not otherwise seek treatment, or perhaps drop out of treatment prematurely.
Integrated health care programs. Within samples of pregnant and postpartum women,
researchers found that integrated substance use treatment programs have demonstrated promise
in meeting the needs of pregnant and postpartum mothers. These programs take a holistic
approach to substance use treatment in order to address substance use as well as other areas of
well-being that might influence women’s sobriety or challenge their ability to engage in
treatment. Such programs typically combine case-management, psychological, and medical
services.
Jansson and colleagues (1996) evaluated the outcomes from one such program and
compared them with outcomes from a group of matched controls. Participants were patients at
the Center for Addiction and Pregnancy, a comprehensive care program developed by the
Maryland State Alcohol and Drug Abuse Administration and the Johns Hopkins Bayview
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Medical Center. Participants were primarily African-American (85%) and demonstrated some
high risk characteristics upon admission, including high unemployment rates (67.7%), criminal
justice system involvement (16.1% on probation or parole and 56.5% endorsing previous
arrests), and histories of mental health concerns including depression (48.4%), anxiety (21.0%),
and suicidal ideation (32.3%). Jansson and colleagues (1996) found that compared to women in
the comprehensive care program, matched controls were 2.5 times more likely to have infants
requiring NICU stays. Furthermore, NICU stays were, on average, six times longer for controls
than for infants of women participating in the comprehensive care program. Collectively, the
savings in hospital costs amounted to about $5,000 per mother-infant pair. Two later studies
demonstrated that a particularly important component of integrated care programs might be case
management services, as intensifying or providing more case management has been related to
better treatment retention, lower substance use rates, and higher rates of child custody retention
(Jansson et al., 2003; 2005).
Meta-analytic and systematic reviews of integrated program outcome data have reported
similarly positive findings. One meta-analysis of ten studies from 1990 to 2009 found that
integrated substance use programs, compared to non-integrated stand-alone substance use
treatment, were related to better birthing outcomes including higher birth weights, larger head
circumferences, fewer birth complications, fewer positive toxicology screens, and fewer pre-term
births (Milligan et al., 2011b). Milligan and colleagues (2011b) also found that participation in
integrated programs was related to more prenatal visits. More recent systematic reviews of
integrated substance use treatment for mothers have corroborated these findings. Niccols and
colleagues (2012a) examined child outcomes in a literature review of 13 studies of integrated
substance use treatment for mothers from 1990 to 2011. Two of these studies included non-
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treatment comparison groups; the collective results of these studies indicated that children of
women in the integrated programs demonstrated superior outcomes in terms of growth
measurements following birth (i.e., weight, height, and head circumference) as well as emotional
and behavioral development. Niccols and colleagues (2012b) conducted a separate systematic
review of integrated substance use programs and found similarly positive effects for mothers. Of
the 31 studies reviewed (dated from 1990 to 2011), three were randomized trials that included
treatment-as-usual comparison groups. These studies collectively attributed a small effect in
improved parenting to the integrated substance use programs. Furthermore, these studies found
that improvements in parenting skills were related to particular aspects of the integrated
programs, including participation in attachment-based parenting interventions and having one’s
children live with them at the facility. Improvements in parenting also were found to be related
to overall maternal mental health and well-being (Niccols et al., 2012b). In terms of treatment
engagement, a systematic review by Milligan and colleagues (2011a) found that integrated
treatment programs, compared to non-integrated treatment programs, were related to more days
in treatment. It is likely that the success of integrated healthcare programs lies primarily in their
ability to address many of the barriers described above due to their multifaceted, wraparound
approach and variety of care providers. Furthermore, some researchers have suggested that
access to prenatal medical services may serve as a gateway to mental health care involvement,
and that combining services obviates the need for patients to navigate the sometimes limited
availability of stand-alone mental health services (Bien et al., 1993).
Family therapy models. Some research has indicated potential benefits for moving
away from individualistic models of therapy to offering substance use treatment in the context of
couple or family therapy. A brief intervention trial by Chang and colleagues (2005) offered
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partner-involved treatment to obstetric patients who had engaged in prenatal alcohol use. A total
of 304 pregnant women and their partners were randomized to the brief intervention condition or
assessment only control group. Participants in the brief intervention condition received a single
25 minute session delivered by a nurse practitioner or the study’s principal investigator. This
session was formatted to include a knowledge assessment with feedback, a section on contracting
and goal setting, behavior modification, and a summary discussion. Following the postintervention assessment, Chang and colleagues (2005) found that alcohol use declined for both
the treatment and control groups, but among pregnant women identified as heavy drinkers at the
time of study enrollment, the brief intervention was more effective than assessment alone.
Chang and colleagues (2005) also were able to test the potential benefit of including a partner in
treatment, as an unintended subsample of 14 participants had partners who did not participate in
the brief intervention. Thus, Chang and colleagues (2005) compared the results of this subsample
to the 118 participants who received the brief intervention as planned. Ultimately they found that
the brief intervention was more effective for heavier drinking women who participated with a
partner. Given the prior research that has indicated the benefits of partner-involved treatment
(McCrady et al., 1991; 2009; 2017), it seems plausible that the presence of a partner could have
accounted for the observed treatment gains. However, it also is possible that participants with
absent partners represented a subsample with overall lower levels of social support or perhaps
greater relationship distress. The lack of randomization for this analysis makes it difficult to rule
out this possibility or draw causal conclusions regarding the benefit of partner-involved
treatment. Nevertheless, these findings suggest a potential benefit of focusing treatment efforts
on environmental and social factors in addition to individual factors.

10

Brief interventions in primary care settings. Individual treatment for pre- and postnatal substance use has often been studied in brief intervention format using participants from
obstetric care offices. Fleming and colleagues (2008) spearheaded one such study through their
Healthy Moms Project. This research initiative recruited women who were receiving routine
postpartum care. Potential participants were screened initially and determined to be at high risk
of alcohol misuse based on their quantity and frequency of use prior to or during pregnancy. In
total, 235 participants were randomized to receive the brief intervention or usual care. The brief
intervention consisted of four 15 minute sessions, guided by motivational interviewing and
cognitive behavioral therapy concepts. At six months following treatment, Fleming and
colleagues (2008) found that women who received the brief intervention reduced their alcohol
use to a significantly greater extent than the control group.
In another study, Yonkers and colleagues (2012) conducted a trial of a brief intervention
for pregnant mothers that combined motivational enhancement therapy with cognitive behavioral
therapy into six 30 minute sessions delivered by trained nurses. These sessions were
administered at an obstetrics office, alongside the patients’ prenatal and immediate postpartum
care appointments. This intervention was compared to a brief advice condition, which was
delivered by the participants’ physicians and lasted about one minute per visit. The outcome of
interest was days of use in the three months prior to and three months following delivery.
Yonkers and colleagues (2012) found that both the intervention and brief advice control groups
demonstrated a typical pattern of reducing their combined drug and alcohol use over the course
of pregnancy and increasing use following delivery. However, Yonkers and colleagues (2012)
found no significant differences between groups in the percentage of using days during the two
assessment periods, before and after delivery.
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In a more recent study, Rubio and colleagues (2014) presented data from a randomized,
controlled, effectiveness trial of a brief motivational enhancement intervention for pregnant
mothers. Participants were 330 women who were at least 20 weeks pregnant at the time of
enrollment, and who had reported at least weekly alcohol use or a binge of four or more drinks
during the year prior to their pregnancy. Participants in the treatment condition were given five
sessions of brief motivational enhancement therapy (Miller, Zweben, DiClemente, & Rychtarik,
1992). Overall, Rubio and colleagues (2014) found that the brief motivational intervention was
not significantly more effective than the treatment-as-usual control condition.
Overall, neither study that began during pregnancy demonstrated significant treatment
effects. One aspect that Yonkers et al. (2012) and Rubio et al. (2014) had in common is that,
perhaps in part because they were recruiting during pregnancy, many of the women in their
studies had already reduced or ceased substance use at the time of assessment, thereby limiting
the amount of change that could occur over the course of treatment. Both Yonkers et al. (2012)
and Rubio et al. (2014) used past substance use as an indicator of risk. Yonkers and colleagues
(2012) assessed for substance use prior to pregnancy, and Rubio and colleagues (2014) assessed
for substance use in the 28 days prior to intake, likely toward the beginning of patients’
pregnancies. However, substance use at the start of the prenatal intervention, which is typically
lower than pre- pregnancy and early pregnancy drinking rates, was what was compared to
follow-up assessments. Yonkers and colleagues (2012) acknowledged this possibility of a ceiling
effect, also noting that their brief intervention might have been more effective in a higher risk
sample.
Computerized brief interventions with postpartum women. As exemplified above,
many of the intervention studies targeting prenatal or postpartum substance use have been
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conducted with samples of women receiving routine obstetrics care. A key benefit of recruiting
from obstetric care facilities is that it targets women who might not otherwise seek treatment for
their substance use. Brief interventions in primary care settings might address some barriers by
providing a convenient way to receive services while getting routine medical care. Brief
interventions also have the potential to be cost effective for both the patient and the hosting clinic
(Handmaker, Miller, & Manicke, 1999; Handmaker & Wilbourne, 2001; Jannson et al., 1996;
McCollister & French, 2003). Furthermore, brief interventions might serve as stepping stones to
other treatment providers and community services if longer-term counseling is desired.
Nevertheless, interventions based in obstetric clinics neglect a substantial portion of the
target population, particularly those who may lack the resources to seek routine obstetric care;
and much of the research on prenatal alcohol use in primary care facilities has been conducted
with samples of primarily white non-Hispanic, middle class, English-speaking women (e.g.,
Chang et al., 2005; Fleming et al., 2008; Wilton et al., 2009). Ondersma and colleagues (2014)
noted that although not all women seek routine prenatal care, most women in the U.S. give birth
in hospitals. Thus conducting hospital intervention trials with women shortly after birth may be
a way to target a more representative sample. Ondersma and colleagues (2005; 2007; 2014;
2016) developed a computerized substance use intervention, intended to be integrated with
routine hospital care following birth. The intervention is delivered in a single session by an
animated narrator and involves three major components guided by motivational interviewing and
brief intervention tenets: (a) computerized feedback based on the participant’s self-reported drug
use, consequences, and readiness to change, (b) elicited interaction in which the participant
chooses from a list of pros and cons those that are most applicable to themselves, and (c) a
summary and optional goal-setting. Randomized trials of this intervention have been conducted
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for both alcohol and drug use. In each study, participants were recruited from hospital settings
shortly after giving birth, and samples were constituted primarily of lower income, African
American mothers (81.3%-97.2%). An earlier randomized trial of this intervention (2007) was
tested with women who reported high-risk illicit drug use prior to pregnancy. Participants were
assessed for drug use shortly after birth and reassessed four months following. A significant
effect was found favoring the intervention group, such that controls tended to demonstrate higher
levels of drug use at the four month follow-up assessment. A later randomized trial of the
computerized intervention (2014) found that drug use was lower for the intervention group
compared to controls at three months follow-up, but not six months follow-up. This indicated
that although the intervention demonstrated some initial gains, benefits were not maintained over
the extended assessment period. This may have been due partially to additional components
offered in the earlier randomized trial that were not included in the later randomized trial; the
omitted components included an incentive for seeking additional treatment and two added
motivational mailings. Ondersma and colleagues (2016) also tested this computerized
intervention with recently postpartum women demonstrating high risk alcohol use prior to
pregnancy. Although qualitative data indicated that the intervention was well-received by
participants (Ondersma et al., 2005), quantitative measurement of alcohol use trends following
birth indicated no significant differences between the intervention group and controls at three
months follow-up (Ondersma et al., 2016). It is possible, again, that these samples were
representative of slightly lower risk individuals given that inclusion criteria were based on prepregnancy rather that during-pregnancy substance use rates. In line with human-delivered brief
intervention research, it is possible that computerized brief interventions might be more effective
with higher risk samples. It also is possible that human factors such as empathy and positive
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regard are crucial and partially accountable for the lack of effects demonstrated by computerized
interventions. Although computerized brief interventions have yielded mixed results, it is
possible that their demonstrated accessibility and feasibility warrant further research
consideration.
Interventions with community samples. In continued effort to address the gap in
diversity within treatment samples, some researchers have sought participants outside medical
care settings. As an example, O’Connor and Whaley (2007) conducted brief intervention trials
in 12 Special Supplemental Nutrition Programs for Women, Infants, and Children (WIC) centers
in Southern California. They recruited a low income minority-majority sample of 345 pregnant
women who were still drinking at the time they were screened. Participants were randomized to
either the brief intervention or an assessment-only condition. As a part of the usual WIC
program, participants were already receiving individual nutrition education. The brief
intervention in this study involved adding a workbook to be completed at these meetings with a
nutritionist. The workbooks included components of education and feedback, cognitive
behavioral techniques, goal setting, and contracting related to alcohol use. Follow-up data
indicated that women who had received the brief intervention were five times more likely to be
abstinent by the third trimester, compared to women who had received assessments only.
In another minority-majority sample, Field and colleagues (1998) provided educational
and social services to adolescent postpartum mothers in a vocational program. The treatment
group consisted of poly-substance using mothers who had had substance-exposed pregnancies.
Outcomes from this group were compared to two control groups: one without substance use
histories and one with substance use histories who did not receive treatment. Participants in the
treatment condition attended half-day sessions of school, which included vocational and
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parenting classes along with social skills, self-care, and substance use treatment. The substance
use treatment portion included group therapy, psychoeducation, urine tests, 12 step self-help
groups, and individual therapy. Participants were additionally provided with instrumental
support through child care, vocational advisement, and housing assistance. Several health
indicators were monitored over the course of the intervention and compared between groups. At
the start of treatment, substance-using participants were significantly higher on measures of
depression and anxiety, and assessed to have inferior interactions with their infants, compared to
non-substance using participants. By the 6th month of treatment, these differences between
groups had diminished. They also found that compared to non-treatment controls, the mothers
with drug exposed pregnancies demonstrated fewer incidents of relapse, fewer repeat
pregnancies, higher rates of school completion, and more job placements following the program.
Thus the success in multiple domains reported by this study seems to mirror the multiple benefits
found by other wraparound service providers as described above (Milligan et al., 2011a; Niccols
et al., 2012b).
Collectively, the above treatment studies indicate that pre- and post-natal substance use
interventions seem to be most successful when targeting high risk clients, providing instrumental
support, and taking into account the client’s larger social context. Given the evidence that some
interventions might be particularly helpful for more disadvantaged women (Field et al., 1998;
O’Connor & Whaley, 2007), an ongoing challenge is to determine what discourages women
from seeking treatment so that those barriers can be addressed. Seeking study samples from the
community in lieu of medical centers may help illuminate these barriers, and yield more
generalizable findings through the recruitment of more diverse samples.
Alternative Treatment and Help-Seeking Preferences
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There is consistent evidence to suggest that immigrant and minority community members
continue to be an underserved population in treatment. For example, in a survey study of
pregnant and postpartum adolescents entering substance use treatment, Coleman-Cowger (2012)
found that despite comparable levels of treatment need as indicated by co-occurring diagnoses,
criminal justice system involvement, and histories of trauma, African American and Hispanic
girls received less mental health treatment compared to their Caucasian counterparts.
Furthermore, substance use treatment outcome data indicate poorer outcomes for Latinx clients
relative to the general population, despite comparable levels of overall use (Alvarez et al., 2007).
Given these treatment disparities, some investigators have looked into whether ethno-cultural
background influences help-seeking preferences, and whether alternative support is sought in
lieu of western health services. Data on women’s help-seeking preferences are lacking for
mothers with pre- or postnatal substance use concerns; however several studies have examined
the treatment preferences of pregnant and recently postpartum women experiencing depression
or other emotional problems. For instance, Alvidrez and Azocar (1999) found that Black, Latina,
and White women in obstetrics settings collectively preferred individual therapy and
psychoeducational classes about general health, followed by group therapy, prevention
programs, and mood management classes. Medication was found to be least desirable. Nadeem
and colleagues (2008) interviewed women from low-income service providers, such as WIC and
Title X family planning clinics, and sought to determine whether ethnic differences were seen in
treatment experiences and preferences. Their sample was made up primarily of U.S.-born Black
participants (n=873) and immigrant Latina participants (n=736), along with U.S.-born White
participants (n=145), Immigrant Black participants (n=101), and U.S.-born Latina participants
(n=33). Participants who had self-identified as having an emotional problem were asked about
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their preferences and experiences with five different sources of help including medication,
individual counseling, group counseling, family and friend support, and faith. The researchers
found that only 10% of those with an emotional problem were receiving mental health treatment.
Of the entire sample that endorsed having an emotional issue, whether or not they were receiving
treatment, differences by ethnic group were seen in which help sources participants viewed as
potentially helpful. With the exception of U.S.-born Latinas, minority women were less likely
than White women to report psychotropic medication as potentially useful. Differences also
were seen in therapy preferences, as immigrant Latinas were more likely to endorse individual
and group therapy as potentially helpful compared to White women. In terms of alternative
forms of support, minority women, minus the U.S-born Latinas, were more likely than White
women to report faith and spirituality as potentially helpful. Groups did not differ in their
endorsements of family and friends as potential sources of support. Most of the participants in
this sample were uninsured, which likely affected participants’ access to care and could have
influenced attitudes about treatment. In a U.K. study, in which participants were recipients of
universal healthcare, some differences in help-seeking preferences still were noted. Within a
sample of White British, Black Caribbean, and Bangladeshi participants who met criteria for a
mental health problem, Rüdell and colleagues (2008) found that White participants were more
likely than the other groups to use self-help strategies and seek social support, and less likely to
engage in faith-based healing practices. Both White and Black participants reported greater use
of complementary treatments such as massage or traditional healers. Bangladeshi participants
were more likely to endorse medication as a treatment choice, relative to the other groups.
Immigration status also was related to treatment preferences, as self-help strategies, social
support, and complementary treatment were endorsed more by non-migrants and participants
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who had migrated as children, compared to adult migrants. Faith based treatment was preferred
less by non-migrant participants, compared to the two migrant groups. Overall, Rüdell and
colleagues (2008) also found that, rather than serving as a replacement for western medicine,
seeking help from family and traditional healers was related to the use of primary care. This
finding suggests that those who seek help for a mental health issue may do so in a variety of
ways, whereas those who are less likely to seek help through Western means also may be less
likely to seek help from family or community members. Whether greater flexibility in helpseeking preferences actually influenced mental health outcomes was not assessed in either of the
above studies, but some researchers have indicated that flexibility, rather than access to any one
particular type of care, is a key component in health disparity outcomes (Diez Roux, 2012).
Neither of the above studies was specific to pre- and postnatal mothers with substance
use concerns; studies of alternative help seeking behaviors and preferences in this population are
lacking. Given the disparities in women seeking substance use treatment, especially women of
ethnically diverse backgrounds, clarifying the factors that underlie differences in attitudes about
treatment in this population is needed.
Health Disparity Models
Mechanisms underlying the observed disparities in women seeking substance use
treatment have not been fully clarified. However, a number of causal and mediating factors have
been suggested as influencing the persistence of disparities in health more generally. As an
example, the Fundamental Cause Model posits that social conditions perpetuated by socioeconomic disparities are the root causes of health disparities via their impacts on access to care
(Diez Roux, 2012). Under the original model developed by Link and Phelan (1995), it was
proposed that health disparities persist over time because of a consistent socioeconomic gradient
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in society, in which people of higher socio-economic status consistently have access to a wider
range of resources, which allows for greater flexibility in their ability to take preventative health
measures and obtain higher quality care when needed. Such instrumental advantages include
financial solvency, mobility, time flexibility, access to technology, and knowledge of available
resources (Diez Roux, 2012; Jessup et al., 2003; Phelan, Link, & Tehranifar, 2010; Yonkers et
al., 2012). Although there is substantial evidence to support this model, it has a singular focus
on socio-economic barriers, neglecting the potential roles of cultural and attitudinal barriers.
Williams (1997) expanded upon the original Fundamental Cause Model to include culture, racial
prejudice, economic structures, and political and legal inequalities as fundamental causes of
racial health disparities. Under this model, racial prejudice is explained to underlie legal policies
and ensuing economic structures that systematically limit socioeconomic mobility. Thus through
racism, race has been associated with socioeconomic status, which in turn, directly impacts
health.
A key characteristic of the Fundamental Cause Model is its emphasis on distal causes that
persist over time (i.e., SES and ethnicity). In contrast, the Pathways Model of health disparities
gives greater consideration to the mediating pathways through which SES and ethnicity are
linked with health outcomes (Diez Roux, 2012). Some of the proposed mediating pathways have
included barriers and resources, acculturative processes, and health care. It is thought that these
pathways are more mutable than distal underlying causes (Diez Roux, 2012). Thus, while
focusing on mediating pathways neglects the larger structure of social injustice to some extent,
attending to mediating pathways may be one way to effect more immediate change on a smaller
scale.
Ethno-Cultural Identity as a Key Factor in Substance Use Treatment Disparities
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Diez Roux’s (2012) Pathway Model suggests that acculturative processes may serve as
mediating pathways underlying the relation between SES and health outcomes. The association
between instrumental resources and mental health outcomes has been well established among
pregnant and postpartum mothers struggling with substance use. However, the role of cultural
factors in this relationship has been given little attention in the pre- and postnatal substance use
literature. Outside the literature on pre- and postnatal substance use, several studies have
indicated the potential for cultural identity to have strong associations with substance use, and in
some cases, serve as a protective factor.
Acculturation and enculturation have been studied extensively in relation to substance
use, particularly among immigrant community members. Sun and colleagues (2016)
operationalized these constructs as “adaptation into mainstream group” (acculturation) and
“adherence to culture of heritage” (enculturation). Much of the research on substance use and
acculturation has been done using male, adolescent, or college samples, and they converge on a
similar conclusion regarding the positive association between acculturation and higher rates of
substance use (Gil, Wagner, & Vega, 2000; Ortega et al., 2000; Schwartz et al., 2010). More
specific to women and substance use, Vega and colleagues (1998) found that within a sample of
Mexican-origin California residents, acculturation was associated with greater drug use among
both men and women; however the effect was stronger for women. In a clinical trial sample of
Hispanic participants, Lee and colleagues (2014) found that acculturation was not associated
with alcohol use in men; however acculturation was associated with more hazardous drinking in
women. Thus findings from both a community and treatment sample have indicated stronger
associations between acculturation and substance use among Hispanic women, relative to their
male counterparts.
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Unfortunately most studies in the substance use literature focus unitarily on acculturation,
neglecting the potential protective factor of enculturation. Furthermore, given that mainstream
cultural values have the potential to conflict with cultural values of heritage, enculturation and
acculturation have been frequently conceptualized as mutually opposing processes. Although
there is literature to support an inverse association (e.g., Berry & Annis, 1974), study outcomes
for this construct frequently have been influenced by unilinear measurement models. Using
bilinear measurement models, several studies have demonstrated a more nuanced process by
which individuals may endorse both acculturation and acculturation strongly (integration), either
acculturation or enculturation alone (assimilation or separation, respectively), or neither
(marginalization; e.g., Berry, et al. 1989; Yoon et al., 2013). Nevertheless, some studies still
indicate a potentially conflicting association, particularly when taking family contextual factors
into account (Dinh et al., 2013)
Research generally has indicated that an integrated cultural identity is related to more
favorable mental health outcomes, whereas scoring high on acculturation alone has been
associated with more negative outcomes. Reflecting this, one meta-analysis analyzed 325
studies and categorized study dependent variables into positive mental health outcomes versus
negative mental health outcomes, concluding that high endorsement of both acculturation and
enculturation (integration) was most strongly associated with more positive mental health
outcomes (Yoon et al., 2013). Within a sample of Latino men seeking substance use treatment,
Lopez-Tamayo, Seda, and Jason (2016) found that patients who endorsed higher enculturation
values reported fewer years of substance use while in treatment. While acculturation appears to
have negative associations with substance use outcomes, this association appears to be strongly
moderated by enculturation. Thus ethnicity as well as flexibility with one’s ethnic identity
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appears to influence health behaviors; however how this relationship manifests among mothers
with substance use concerns is unknown.
Original Study Aims and Hypotheses
Given the disparities in help-seeking and receipt of services among women with
substance use concerns, particularly pregnant and postpartum mothers of low income and
minority background, a clearer picture of where and why needs are being unmet is needed for
this specific population. Since most studies of treatment needs and perceived barriers have been
based on treatment seeking samples, more studies of individuals who are less treatment engaged
and more economically and ethnically diverse are needed. To remedy these gaps in the
literature, this study had three overarching aims: (1) to characterize the help seeking preferences,
perceived treatment barriers, and attitudes about substance use treatment of pregnant and
postpartum women with histories of substance use problems, in an ethnically diverse, bilingual
sample from low-income sectors of the community; (2) to examine the relation between
perceived barriers and (a) help seeking preferences, (b) attitudes about professional treatment, (c)
treatment engagement, (d) substance use, and (e) subjective well-being; and (3) to determine
whether the associations tested in aim 2 are moderated by cultural identification.
Aim 1: Characterize help seeking preferences, perceived treatment barriers, and
attitudes about substance use treatment.
Aim 1a. Help seeking preferences. Among pregnant and postpartum mothers endorsing
a substance use problem, which treatment types or care resources are perceived as more or less
desirable?
Hypothesis 1a-1: Individual therapy will be endorsed more frequently relative to group
therapy, faith-based support, and medication.
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Hypothesis 1a-2: Differences between ethnic groups will be seen such that mothers of
minority background will report more favorable attitudes toward faith-based services, relative to
white counterparts.
Aim 1b. Perceived treatment barriers. Among pregnant and postpartum mothers
endorsing a substance use problem, what are their perceived barriers to substance use treatment?
Hypothesis 1b-1: Participant reports will reflect higher scores on stigma-related relative
to non-stigma-related barriers to treatment.
Hypothesis 1b-2: Participants of ethnic minority background will report more stigmarelated barriers, relative to white participants.
Aim 1c. Attitudes about substance use treatment. How do pregnant and postpartum
mothers with substance use concerns perceive professional treatment services?
Hypothesis 1c: Women of ethnic minority background will report less positive attitudes
about professional substance use treatment than non-minority participants.
Aim 2: Perceived barriers’ association with substance use, treatment, and mental
health. Among pregnant and postpartum mothers with substance use concerns, how are
perceived treatment barriers related to (a) help-seeking preferences, (b) attitudes toward
professional care, (c) treatment engagement, (d) substance use, and (e) subjective well-being?
Hypothesis 2a: Endorsement of more treatment barriers will be related to fewer help
seeking preferences.
Hypothesis 2b: Endorsement of more treatment barriers will be related to more negative
attitudes about professional treatment.
Hypothesis 2c: Endorsement of more treatment barriers will be associated with lower
levels of treatment engagement.
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Hypothesis 2d: Endorsement of more treatment barriers will be related to greater severity
of substance use.
Hypothesis 2e: Endorsement of more treatment barriers will be associated with lower
levels of subjective well-being.
Aim 3: Cultural identity as a moderator. Does high endorsement of both enculturation
and acculturation moderate the associations specified in Aim 2?
Hypothesis 3a: High endorsement of both enculturation and acculturation will serve as a
moderating protective factor, such that participants identifying as high on both scales will
demonstrate weaker associations (specified in Aim 2) relative to participants identifying as
separated, assimilated, or marginalized (see Figure 1).
Method
Participants
Participants were 27 women, ages 23-43 (M = 31 years). Study inclusion criteria required
that participants be (a) 18 or older, (b) able to speak English or Spanish, (c) currently pregnant or
recently postpartum (within two years of giving birth), and (d) positively screened for
problematic substance use (either within the past year, or a year prior to their pregnancy).
Problematic substance use was determined by a minimum score of 8 on the AUDIT (Saunders et
al., 1993) or 3 on the DAST (Skinner 1982). Sources of recruitment for the present study sample
included substance use treatment centers (n = 21), WIC offices (n = 2), temporary housing
programs (n = 1), online community boards (n = 1), and word of mouth (n = 2; see Table 1).
Participants self-identified as Hispanic (44.4%), White (25.9%), Native American
(14.8%), Multi-Ethnic (11.1%), or African American (3.7%). All participants spoke English, and
nearly half (n = 13) were bilingual in a second language (primarily Spanish, n = 10). Average
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annual household income was $22,036; although 37.0% of the sample reported $0 income and
81.5% of the sample met poverty guidelines for financial, medical, and/or nutritional assistance
(NM Human Services Dept., 2018a; 2018b). Most participants were medically insured (96.3%)
and born in New Mexico (70.4%). At the time of study interviews, 9 (33.3%) participants were
pregnant and 18 (66.7%) participants were postpartum. Participants reported a mean of 1.5
children living in the home. Additional sample demographic information is provided in Table 2.
Measures
Qualitative interview. A short qualitative interview was conducted and included the
following questions: (a) Tell me about your family; who lives with you at home? (b) From your
perspective, do you believe alcohol or drug use has been a problem in your life? (c) Have you
ever received treatment for alcohol or drug use in the past? If yes, what helped encourage you to
seek treatment and attend appointments? What did you learn or gain from treatment? (d) What
about seeking treatment was difficult or undesirable?
Demographic information. Demographic information was collected using the
Demographic Interview 2.2 (CASAA Research Division, 1997). This measure included
questions regarding age, gender, ethnic identity, employment status, household income, and
education. The Demographic Interview 2.2 was adapted to include bi-ethnic and multi-ethnic
identity options as well as questions to elicit the participant’s country of birth, number of years
lived in the United States, and health insurance status.
Barriers to substance use treatment. Barriers to treatment were assessed using the
Barriers to Access to Care Evaluation scale version 2 (BACE v2; Clement et al., 2012). The
measure was adapted to be specific to substance use treatment. In its original form, the BACE is
a 36-item measure that includes subscales for stigma-related and non-stigma-related barriers.
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Items query participants about their experience of barriers such as “feeling embarrassed or
ashamed” (stigma-related) or “having problems with childcare while I receive professional care”
(non-stigma-related). Response options range from 0 (“not at all”) to 3 (“a lot”), with higher
scores indicating a greater barrier to treatment. It ends with spaces for an open-response option
to record participant-reported barriers that were not listed in the measure. The BACE v2 has
been shown to have acceptable internal consistency (α = .72; Kuhl et al., 1997) and good testretest reliability (kappa values .61-.80; Clement et al., 2012). A shortened 30-item version of the
measure was developed by omitting five of the original items that garnered low response rates
and combining two of the original items that yielded high correlations (BACE v3; Clement et al.,
2012). Although the shorter BACE v3 has been recommend for future use, the BACE v2 was
administered for the present study as the BACE v3 was not developed using a sample of
pregnant or postpartum women with substance use concerns, and some of the items omitted
appeared relevant to this population. Within this study sample, the adapted measure showed
good internal consistency for the full measure, as well as its stigma and non-stigma subscales (α
= .93, α = .89, α = .89, respectively).
Drug Use. Severity of drug use was measured using the Drug Abuse Screening Test
(DAST-10; Skinner et al., 1982). The DAST was developed as a brief screener for harmful drug
use. The DAST-10 is a shortened version of the original 20-item measure. It consists of 10
questions about drug use behavior, with binary “yes” or “no” response options. In its original
20-item form, tests within a clinical sample yielded strong internal consistency reliability (α =
.92; Skinner 1982). Within a clinical sample of 501 patients, DAST scores between 5 and 6 were
85% accurate in detecting drug use disorders according to DSM-III criteria, indicating scores
within that range could be used as a benchmark for problematic drug use (Gavin et al., 1989).
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The shorter DAST-10 has been validated cross-culturally. Within a clinical sample of Spanish
speakers in Mexico, a cutoff score of 3 identified 98% of the patients with a substance use
disorder determined by the Mini International Neuropsychiatric Interview 5.0 (MINI 5.0;
Villalobo-Gallegos et al., 2015). Within the same sample, reliability was strong (α = .80;
Villalobo-Gallegos et al., 2015). However, among a sample of pregnant women screened for
drug use, hair and urine analysis indicated 24% of participants tested positive for drug use and
the DAST sensitivity in detecting use was determined to be only .47 (Grekin et al., 2010). This
finding indicated that this self-report measure may be less effective when used to assess drug use
during pregnancy. Hence for the present study, two time periods were assessed: past year and
the year prior to pregnancy.
Alcohol Use. Severity of alcohol use was assessed using the Alcohol Use Disorders
Identification Test (AUDIT; Saunders, Aasland, Babor, de la Fuente, & Grant, 1993). This is a
measure intended to detect harmful levels of drinking and the possible presence of an alcohol use
disorder (Allen, Reinert, & Volk, 2001). Ten items ask respondents to rate their drinking
behaviors on five- and three-point Likert-type scales, yielding scores that range from 0 to 40
(e.g., “How often do you have six or more drinks on one occasion?”). A cutoff score of 8 has
been suggested as indicating hazardous alcohol use (Conigrave, Hall, & Saunders, 1995). The
AUDIT has demonstrated good internal consistency (Cronbach’s alphas in the .80s; Allen,
Litten, Fertig, & Babor, 1997) as well as good test-retest reliability (r = .88; Daeppen, Yersin,
Landry, Pecoud, & Decrey, 2000). For the present study, two time periods were assessed: past
year, and the year prior to pregnancy.
Help seeking preferences. An adapted measure from Nadeem and colleagues (2008) was
intended to assess help seeking preferences, engagement, and flexibility. In a study of mental
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health care preferences within an ethnically diverse sample, Nadeem and colleagues (2008)
asked participants who had indicated an emotional problem, “Do you think these problems could
be helped with any of the following?” Participants were asked to provide “yes” or “no”
responses to five items: “medication, individual counseling, group counseling, family and friends
support, and faith.” This measure was adapted to include a category for complementary health
practices. The initial question was adapted to be specific to substance use concerns.
Endorsement of a greater number of categories was expected to indicate greater flexibility in
participants’ treatment preferences. Internal consistency for the adapted measure was low (α =
.53).
Attitudes about professional treatment. Attitudes regarding professional treatment
were measured using the abbreviated Attitudes Toward Seeking Professional Psychological Help
scale (ATSPPH; Fischer & Farina, 1995). This is a 10-item measure, shortened from its original
29 item form (Fischer & Turner, 1970). Respondents are instructed to read statements and
indicate their “agreement, probable agreement, probable disagreement, or disagreement.” Items
include statements such as “The idea of talking about problems with a psychologist strikes me as
a poor way to get rid of emotional conflicts,” and “If I were experiencing a serious emotional
crisis at this point in my life, I would be confident that I could find relief in psychotherapy.” The
ATSPPH has demonstrated good internal consistency (α = .84) as well as good test-retest
reliability (r = .80 over one month; Fischer & Farina 1995). The language in this measure was
adapted for gender agreement to reflect the female respondents in the present study, as well as to
be more specific to substance use treatment and “counseling” rather than psychotherapy. Internal
consistency on the adapted measure was acceptable (α = .66).
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Treatment engagement. Items 8-15, 22-25, and 29-35 from the Form 90 (Miller, 1996)
were used to assess treatment engagement, including types of treatment sought and time spent in
treatment. The Form 90 in its original form includes a calendar measure and is intended to
assess substance use, time in treatment, and some aspects of general functioning over the course
of 90 days. The items that were used for this study, including days in religious attendance, days
in medical care, and days in inpatient treatment, have shown good temporal stability (r = .79-.98,
.74-.99, .63-.99, respectively; Tonigan, Miller, & Brown, 1997; Westerberg, Tonigan, & Miller,
1998).
Subjective well-being. Subjective well-being was measured using the Satisfaction with
Life Scale (SWLS; Diener et al., 1985). This is a five-item measure in which participants read a
series of statements and are asked to rate the extent to which they agree or disagree with each
statement. Four response options are presented on a Likert-type scale and range from 1
(“strongly disagree”) to 4 (“strongly agree”), with higher scores indicating greater life
satisfaction. Items include statements such as “The conditions of my life are excellent,” and “In
most ways my life is close to my ideal.” The SWLS has demonstrated high internal consistency
(α = .87) as well as acceptable temporal stability (r = .87 over 2 months and .54 over four years;
Pavot & Diener, 1993). However, the measure also has been shown to be sensitive to changes in
clinical samples undergoing treatment (Pavot & Diener, 1993).
Acculturation and enculturation. Acculturation and enculturation were measured using
the Abbreviated Multidimensional Acculturation Scale (AMAS-ZABB; Zea et al. 2003). The
AMAS-ZABB is a 2-subscale instrument developed to measure acculturation and enculturation
in three dimensions: identity, cultural competence, and language competence. Respondents are
asked to rate 42 items on a 4-point Likert-type scale ranging from 1 (“strongly disagree” or “not
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at all”) to 4 (“strongly agree” or “extremely well”). Higher scores are indicative of higher levels
of acculturation or enculturation. As an example, one of the acculturation items asks, “How well
do you know popular American newspapers and magazines?” One of the enculturation items
asks, “How well do you speak your native language with family?” Within a sample of Latino/a
participants, the AMAS-ZABB demonstrated good internal reliability for both the acculturation
and enculturation scales (α = .89 and .96; Zea et al., 2003).
Procedures
The original recruitment plan included face-to-face recruitment of women at four local
WIC centers; yet ultimately the WIC Director for NM determined that this procedure was
inconsistent with WIC policy. The centers did, however, continue to support recruitment flyers
being left available in their waiting rooms. Study investigator and research assistants additionally
distributed bilingual recruitment flyers at community centers (e.g., parks, libraries, laundromats,
thrift and grocery stores), medical offices and hospitals, behavioral health treatment centers,
online community boards, and through email and newsprint advertisement. In-person recruitment
took place at a farmers market, flea market, and health fair. See Figure 2 for participant
recruitment and retention data, and Table 1 for a full list of recruitment sources.
Recruitment flyers included the study description, eligibility criteria, and contact
information. Interested participants called the number on the flyer to get more information and to
be screened for eligibility. Study personnel were bilingual Spanish and English speakers. All
phone conversations were conducted in the caller’s preferred language, determined by either how
the caller initiated the conversation, the language used in their voice message, or by asking the
caller about their language preference. Interested and eligible participants were then scheduled
for an interview appointment. Although this issue did not arise, screenings and interviews were
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set to be rescheduled if signs of intoxication were present. For the interview appointment,
alcohol intoxication was tested using saliva test strips.
Participants attended a 60-minute appointment at the Center on Alcoholism, Substance
Abuse, and Addictions (CASAA). Appointment procedures were available in English and
Spanish. The participants’ language preferences were typically determined through their initial
phone screens, though study materials and interviews were available in English and Spanish at
all times. During the interview appointment, participants were first guided though consent
procedures. These included giving the participant a copy of the consent agreement to read,
followed by the interviewer explaining key points of the agreement (i.e., their right to end
participation at any time without penalty, confidentiality limitations, potential risks and benefits),
and lastly offering to answer any remaining questions about the study before signing the consent
document. A copy of the informed consent agreement was given to the participant to keep.
After consent was provided, the assessment portion of the study began with a short
qualitative interview, during which responses from the participant were written down by the
interviewer. Participants were then guided through a series of written questionnaire measures.
Participants were given the option of completing the measures on their own or having the
questions read to them out loud by the study investigator. At the end of their appointment,
participants were given a list of potentially helpful community resources, asked if they had any
questions or concerns about the study, and given a $25 gift card for their participation.
Data Analysis
Prior to testing study hypotheses, basic descriptive statistics were generated to
characterize the sample on socio-demographic, independent, and dependent variables. Next,
preliminary analyses were conducted to ensure that the underlying statistical assumptions for the
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planned analyses were upheld. This included checking for normal measurement distributions,
absence of multicollinearity, homoscedasticity, and linear relationships between independent and
dependent variables. Once underlying statistical assumptions were assessed, the hypotheses for
aims 1-3 were tested. In the case of assumption violation, alternative steps were taken to address
the study aims and hypotheses. These alternative approaches are introduced briefly below and
discussed more thoroughly in the results. Lastly, qualitative data from participant interviews
were used to further characterize the study sample and allow for added quantifiable data.
Aim 1: Characterize help seeking preferences, perceived treatment barriers, and
attitudes about professional care.
Aim 1a. Help seeking preferences. ANOVA was the planned analysis to assess
differences between help-seeking preference categories (e.g., individual or group therapy, faithbased support, and medication), as well as differences based on ethnic identity (hypotheses 1a-1
and -2). Due to severely limited variability within the Help-Seeking Preferences scores, items
from the Form 90 Treatment Engagement measure were used to assess participants’ use of
individual counseling, medication, and religious service attendance. Although these items assess
participants’ use of services rather than their preferences, the items address support services
comparable to those assessed in the Help-Seeking Preferences measure (i.e., counseling,
medication, and religion/spirituality). The items therefore were used to best approximate
participants’ treatment decisions, despite acknowledging that other factors besides preference
may factor into their treatment decisions. Unfortunately these items did not assess for use of
group therapy, specifically. To ensure that the appropriate statistical assumptions were met, a
Wilcoxon test was used to assess differences between types of support. A Mann-Whitney U test
was used to examine potential differences between cultural groups.
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Aim 1b. Perceived barriers. A paired t-test was used to test for differences between
stigma and non-stigma barrier types (hypothesis 1b-1). Given that these subscales are unequal in
size, comparisons between scales were made using average scores in lieu of raw totals. Given
that underlying assumptions appeared to have been met by these measures, the planned
hierarchical regression analyses were performed to test for ethnic differences in stigma and nonstigma barriers (hypothesis 1b-2). Given the small, uneven subsamples of white (n = 6) and nonwhite (n = 20) participants, the 1b-2 analyses were performed using additional indicators of
cultural identity. These included measures of enculturation and second language fluency.
Aim 1c. Attitudes about substance use treatment. Hierarchical regression analyses were
performed to test for ethnic differences in attitudes about professional treatment, while
controlling for socio-demographic variables such as income and education (hypothesis 1c). As
with hypothesis 1b-2 above, this analysis was carried out with three separate indicators of
culture: ethnicity, language, and enculturation.
Aim 2: Perceived barriers’ associations with substance use, treatment, and mental
health. Bivariate correlations were used to examine the association of perceived treatment
barriers with (a) help-seeking preferences, (b) attitudes toward professional care, (c) treatment
engagement, (d) substance use, and (e) subjective well-being (hypotheses 2a-e). The BACE
stigma and non-stigma subscales also were entered into the matrix to characterize their unique
associations with help-seeking preferences, attitudes about professional care, treatment
engagement, substance use, and subjective well-being.
As the Help-Seeking Preferences measure was severely limited in its variability, Form 90
Treatment Engagement items measuring medication use, therapy use, and days in religious
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attendance, were used in its place to facilitate interpretations of a potential relation between
treatment barriers and use of specific support services.
Aim 3: Cultural identity as a moderator. Scores on the enculturation and acculturation
subscales of the AMAS-ZABB were initially intended to characterize participants as highly
acculturated/less enculturated, highly enculturated/less acculturated, high on both scales, or low
on both scales. Given the small size of the present sample and the lower variability shown in the
acculturation scale, a revised plan sought to test enculturation as a continuous measure of
cultural identity and its impact on associations identified in Aim 2. Hierarchical regressions or
partial correlations (depending on assumption verification) were expected to test for cultural
influence on the association between perceived treatment barriers and (a) help-seeking
preferences, (b) attitudes toward professional care, (c) treatment engagement, (d) substance use,
and (e) subjective well-being (hypothesis 3a).
Thematic content analysis of qualitative response data. In line with recommendations
by Maguire and Delahunt (2017), steps were taken to (a) generate codes based on subsets of the
data, (b) discuss unifying themes between coders, (c) code remaining subsets of the data, and (d)
modify or add themes to fit the data following each coding session. This was an open coding
method, as codes were developed in an iterative process. There is literature to suggest that
qualitative studies typically achieve thematic saturation with nine to 12 participants (e.g., Guest,
Brunce, & Johnson, 2006; Hennink, Kaiser, & Marconi, 2017), thus this analysis method was
expected to suit the present study sample size.
Results
Sample Characteristics
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Within the present sample, most participants (55.6%, n = 15) reported subthreshold levels
of alcohol use and were admitted to the study solely on the basis of reported substance use
behaviors. A substantial portion of the sample (37.0%, n = 10) was admitted to the study on the
basis of both illicit substance use and alcohol use. Only two participants (7.4%) reported
problematic alcohol use without co-occurring illicit substance use. Collectively, mean AUDIT
scores for the sample were 6.81 for the year preceding their study interview and 9.52 for the year
preceding pregnancy. Mean DAST scores were 4.93 and 7.74 for the years prior to study
participation and their pregnancy, respectively. Among participants reporting illicit substance
use, opiates and methamphetamine were most frequently named as primary drugs of choice (see
Table 4). In terms of treatment engagement, a small portion of the sample (n = 3, 11.1%)
reported no experience with treatment for drug or alcohol concerns; they did, however, report
past experience with treatment for other emotional or psychological concerns. Most participants
reported at least some experience with substance use treatment over the course of their lifetime,
ranging between 1 and 730 days in counseling, residential, and/or detox programs. In the 90 days
preceding their last use, participants reported an average of 7.37 days (SD = 17.66) engaged in
substance use treatment. During this same time frame, participants reported an average of 37.00
days (SD = 42.45) taking prescribed maintenance medication, and 27.89 days (SD = 40.00)
taking medication for other psychological concerns. Additional descriptive statistics for the
independent and dependent measures are available in Table 3.
Testing Statistical Assumptions
Distribution statistics for all independent and dependent measures can be viewed in Table
3. Distribution assumptions were upheld for the following measures: Barriers to Access to Care
Evaluation and its subscales, Attitudes Toward Seeking Professional Help, Satisfaction with
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Life, and 90-Day use of medication for mood and psychological concerns. Distributions for 90Day use of opioid maintenance therapy and the DAST (for the year prior to study participation)
were approaching normality. The remaining measures of substance use (AUDIT, DAST for the
year preceding pregnancy), treatment engagement (Form 90 items assessing lifetime engagement
and 90-day use of non-medication services), Help-Seeking Preferences, and
acculturation/enculturation (AMAS-ZABB) failed to meet standard distribution assumptions.
Multicollinearity was checked using the bivariate correlation statistics listed in Table 5, which
gave no indication of redundancy between variables. Homoscedasticity and linear associations
between variables also were ensured prior to carrying out the inferential tests below.
Aim 1: Characterize Help Seeking Preferences, Treatment Barriers, and Attitudes about
Treatment.
Aim 1a. Help seeking preferences. Among pregnant and postpartum mothers endorsing
a substance use problem, which treatment types or care resources are perceived as more or less
desirable? Within this sample, the vast majority of participants endorsed all sources of mental
health support, specifically individual therapy (96.3%, n = 26), group therapy (92.6%, n = 25),
medication (81.5%, n = 22), family and friends (96.3%, n = 26), religion and spirituality (85.2%,
n = 23), and alternative or complementary practices (85.2%, n = 23).
Hypothesis 1a-1: Individual therapy will be endorsed more frequently relative to group
therapy, faith-based support, and medication. Overall, the Help Seeking Preferences measure
did not allow for enough variance to detect differences in preferences for the different support
sources. Items from the Form 90 Treatment Engagement measure indicated a more variable
response pattern when asking participants about their actual use of support services in the 90
days prior to their last use. During this time frame, 18 (66.7%) participants took medication to
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help with a psychological or substance use issue, 12 (44.4%) participants sought counseling for
their substance use, and 11 (40.7%) attended a religious or spiritual gathering. A Wilcoxon
Signed Ranks Test indicated no significant difference in participants’ use of substance use
counseling (M = 3.33 days, SD = 5.64) versus religious or spiritual support (M = 2.11 days, SD =
3.85); Z = -.74, p = .46). The test indicated significantly more frequent use of psychotropic (M =
27.89 days, SD = 40.00) and opioid maintenance medications (M = 37 days, SD = 42.45) relative
to days spent in counseling (Z = -2.20, p = .028; Z = -3.24, p < .001, respectively); although
given that these medications are often prescribed for daily use, this difference does not
necessarily indicate a difference in participants’ perception of helpfulness or favorability of
medication over counseling services. Thus, although these results do not conclusively support or
reject the hypothesis that individual therapy would be favored over other types of support, these
results appear to characterize the present sample as generally open to various types of mental
health support.
Hypothesis 1a-2: Differences between ethnic groups will be seen such that mothers of
minority background will report more favorable attitudes toward faith-based services, relative
to white counterparts. The Mann-Whitney Tests did not detect significant differences between
minority and non-minority participants, nor between bilingual and mono-lingual participants, in
their use of different types of support (see Table 6). These results are inconsistent with the 1a-2
hypothesis that mothers of minority background would report more favorable attitudes regarding
faith-based services, relative to white participants. Nevertheless, it should be noted that these
analyses were based on participants’ actual use of sources of support versus their expressed
attitudes about the source of support.
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Aim 1b. Perceived barriers. Among pregnant and postpartum mothers endorsing a
substance use problem, what are their perceived barriers to substance use treatment? Overall,
this sample indicated a broad range of experience with treatment barriers, with total raw scores
ranging from 11 to 94 (M = 57.93, SD = 25.04).
Hypothesis 1b-1: Participant reports will reflect higher scores on stigma-related
relative to non-stigma-related barriers to treatment. To account for the unequal number of items
in the stigma and non-stigma subscales, mean subscale scores were computed for each
participant (potentially ranging 0 to 3), and comparisons between the subscales were made using
these scores in lieu of raw total scores. Results from a t-test analysis supported the above
hypothesis, such that participants reported significantly greater impact from stigma-related
barriers (M = 1.70, SD = .81) than non-stigma barriers (M = 1.28, SD = .58) in terms of their
access to treatment; t (26) = 3.95, p < .001. Furthermore, limiting the non-stigma scale to
instrumental barriers alone also continued significant differences, such that participants reported
greater impact from stigma barriers (M = 1.70, SD = .81) than instrumental barriers (M = 1.35,
SD = .69); t (26) = 2.74, p = .011).
Hypothesis 1b-2: Participants of ethnic minority background will report more stigmarelated barriers, relative to white participants. On average, both White and non-White
participants rated stigma-related barriers as interfering “quite a lot” with their treatment
engagement on a 0 to 3 scale (M = 1.89, SD = .84; M = 1.64, SD = .81, respectively). Inspection
of both average and raw stigma scores suggested a potential difference between White (raw M =
24.57, SD = 10.88) and non-White participants (raw M = 21.30, SD = 10.57) in a direction
opposite of the one hypothesized, such that White participants appeared to report greater
experience of stigma barriers. However, this observed difference was not significant when tested
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with a hierarchical regression, ∆R2 = .019, ∆F (1, 25) = .490, p = .491. Additional analyses were
conducted to explore potential differences based on enculturation and second language fluency,
but significant effects were not detected (∆R2 = .017, ∆F (1, 25) = .441, p = .513; ∆R2 = .002, ∆F
(1, 25) = .057, p = .813, respectively).
Aim 1c. Attitudes about substance use treatment. How do pregnant and postpartum
mothers with substance use concerns perceive professional treatment services? The sample
mean score of 30.88 (SD = 4.91) on the Attitudes Toward Seeking Professional Psychological
Help scale indicated that, on average, participants rated themselves as being in probable
agreement with positive statements about professional treatment. However, scores ranged from
20 to 39, indicating a spread of both negative and positive views on professional care.
Hypothesis 1c: Women of ethnic minority background will report less positive attitudes
about professional substance use treatment than non-minority participants. Mean total scores
were similar between White (M = 31.00, SD = 6.25) and non-White participants (M = 30.60, SD
= 4.54). Hierarchical regression analyses were used to assess for potential cultural differences in
attitudes about professional care, while controlling for socio-demographic variables such as
income and education. As with aim 1b above, this analysis was carried out with three separate
indicators of culture. However, significant effects were not detected on the basis of ethnicity
(∆R2 = .009, ∆F (1, 23) = .226, p = .639), enculturation (∆R2 = .061, ∆F (1, 23) = 1.544, p =
.227), or second language fluency (∆R2 = .007, ∆F (1, 23) = .168, p = .685).
Aim 2: Barriers’ Associations with Substance Use, Treatment, and Life Satisfaction.
Based on the analyses performed, treatment barriers were not significantly associated
with participants’ substance use behavior, attitudes toward professional care, treatment
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preferences, time spent in treatment, or general life satisfaction. The results from these bivariate
correlations are listed in Table 5.
Hypothesis 2a. It was hypothesized that endorsement of more treatment barriers would
be related to fewer help seeking preferences. Given the limited variability and psychometric
properties of the Help-Seeking Preferences measure, subscales from the Form-90 Treatment
Engagement measure were entered into the analysis to account for actual support services used.
These included days spent in religious attendance, attending therapy, and taking medication.
Nevertheless, a significant association was not demonstrated (see Table 5).
Hypothesis 2b. It was hypothesized that endorsement of more treatment barriers would
be related to more negative attitudes about professional treatment. This was not supported by the
analysis results (see Table 5).
Hypothesis 2c. It was hypothesized that endorsement of more treatment barriers would
be associated with lower levels of treatment engagement. Days spent engaged in various
treatment types, during the participant’s lifetime and 90 days since last use, were entered as
separate variables in the analysis. However, treatment engagement during neither time frame
demonstrated a significant association with barriers (see Table 5).
Hypothesis 2d. It was hypothesized that endorsement of more treatment barriers would
be related to greater severity of substance use. This was not supported by the analyses. Given the
distribution limitations of the DAST and AUDIT measures, days since last use (from the date of
interview) was entered as an additional substance-use indicator in the analysis. Nevertheless, this
too was not shown to be significantly associated (see Table 5).

41

Hypothesis 2e. It was hypothesized that endorsement of more treatment barriers would
be associated with lower levels of subjective well-being. Based on participant’s reports of overall
life satisfaction, this was not supported by the analysis (see Table 5).
Aim 3: Cultural Identity as a Moderator.
Does high endorsement of both enculturation and acculturation moderate the associations
specified in Aim 2? It was hypothesized that high endorsement of both enculturation and
acculturation would serve as a moderating protective factor, such that participants identifying as
high on both scales would demonstrate weaker associations specified in Aim 2. The planned
analyses to detect moderating effects were not conducted given that significant associations were
not detected for the hypothesized variables. Nevertheless, an overarching aim of the original
planned analyses was to characterize cultural influences on independent and dependent variables.
Thus steps were taken to examine direct associations between enculturation and acculturation
and the independent and dependent variables in this study, as well as to further characterize the
sample based on these constructs.
As a sample, all participants scored within the top half of the range on the acculturation
scale. More variability was demonstrated in the enculturation scale such that six participants
(22.2%) scored in the lower half of the scale. Given that acculturation and enculturation are
frequently demonstrated to have an inverse association, it was interesting to find that
acculturation and enculturation were strongly and positively correlated within the present sample
(r = .73, p < .001)). This was thought to have occurred in part due to the inclusion of scores
from White, non-minority participants. A t-test confirmed that participants’ scores on the
enculturation scale were significantly related to their ethnic identity, such that participants
identifying as White endorsed a higher mean Enculturation score (M = 78.57, SD = 4.50), than
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participants identifying as non-White (M = 63.20, SD = 17.68); t (25) = -2.25, p = .034.
Consistent with descriptive data suggesting overall high scores on the acculturation measure,
significant differences in acculturation were not detected between minority (M = 74.58, SD =
7.59) and non-minority participants (M = 79.36, SD = 5.28); t (25) = -1.53, p = .138.
Bivariate correlational analyses detected moderate associations for both acculturation and
enculturation with past year substance use behavior, such that participants who expressed
stronger acculturation and enculturation identities were likely to report less substance use
behavior in the past year (r = -.48, p = .011; r = -.48, p = .011, respectively). Results also
indicated a significant negative relation between the acculturation and enculturation scales and a
subset of items from the BACE indicating family-related barriers to treatment (r = -.40, p = .042;
r = -.42, p = .029, respectively). Thus participants who scored lower on scales of Acculturation
and Enculturation tended to report greater influence from family-related barriers on their
engagement with treatment.
Given that acculturation and enculturation are hypothesized to represent pulls between
one’s culture of heritage and the majority culture, it is possible that including measurement data
from White non-minority participants may have artificially inflated average scores, increased
cohesion between the scales, and truncated variance. For this reason, bivariate correlations were
run separately within each subsample to explore potential associations between acculturation and
enculturation with the measures of substance use, treatment engagement, and barriers to
treatment. The results of these analyses are reported in Table 7. Of note, associations of
enculturation and acculturation with family-related treatment barriers were strengthened within
the subsample of non-White participants (r = -.66, p < .001, r = -.56, p = .010, respectively).
Within the subsample of White participants, reports of fewer treatment barriers, especially
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instrumental and family-related barriers, were strongly associated with participants’ lifetime
substance use treatment engagement (r = -.84, p = .019, r = -.85, p = .016, respectively).
Thematic Content Analysis of Qualitative Interview Responses
Based on participants’ responses to open-ended questions, thematic content analysis was
used to further characterize the sample and supplement gaps in the quantitative data. Broad
themes included participants’ household make-up, positive and negative experiences as mothers,
factors that encouraged treatment engagement, perceived treatment effects, and barriers they
have experienced. All codes and their frequencies are listed in Table 8.
Household. A small majority of participants (51.8%, n = 14) were single mothers,
defined here as living without in-home support from a spouse or romantic partner. Of this subset,
five women (18.5% of the total sample) lived with other adults, usually parents, step-parents, or
grand-parents; and nine (33.3% of the total sample) lived alone with their children. Thirteen
(48.1%) of the participants lived with a spouse or romantic partner, and a small subset of this
group (n = 2, 7.4% of the total sample) had parents or in-laws living in the home as well. Of the
entire sample, most mothers (n = 15, 55.5%) lived with one child, although the number of
children in the home ranged from 0 (due to custody removal, n = 4) to 7.
Experiences as mothers. When asked about their favorite parts of motherhood,
participants most frequently (n = 14, 51.9%) alluded to the affection between them and their
children or the unique bond that they shared. An additional salient theme emerged as participants
often described a sense of purpose they felt after becoming mothers (n = 6, 22.2%). For instance,
one mother stated, “It gives my life more meaning.”
When asked about the more difficult aspects of motherhood, participants most frequently
indicated a lack of support as the most challenging aspect (n = 8, 29.6%). One mother explained,
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“I feel like I’m doing it all alone most of the time.” Several participants also cited an emotional
toll and the amount of patience that is required (n = 6, 22.2%).
Treatment engagement. The majority of participants (n = 24, 88.9%) reported past
experience with alcohol or substance use treatment. Of the subset, most (n = 13, 54.2%) cited
their pregnancy or their child’s health as the primary impetus to their seeking treatment.
Participants’ responses regarding what encouraged their treatment engagement varied widely,
such that more themes with lower frequencies were identified for this broad theme. Nevertheless,
participants also cited self-determination (n = 3, 12.5%), something to occupy time (n = 3,
12.5%), and a lack of choice (e.g., court-mandated; n = 3, 12.5%), as factors motivating their
treatment engagement.
Perceived treatment effects. When asked about what they gained from treatment, most
participants (n = 9, 37.5%) alluded to coping skills for managing urges and emotions. A second
cluster of responses (n = 5, 20.8%) reflected growth in self-compassion. One participant shared,
“I’m learning it’s okay. I’m a work in progress.” A range of experiences were represented in this
sample, as some (n = 4, 16.7%) expressed a lack of treatment gains (e.g., “It’s all talk.”).
Treatment barriers. When asked about the difficult or undesirable aspects of treatment,
most participant responses fit within over-arching themes of instrumental (n = 9, 33.3%) and
emotional (n = 10, 37.0%) barriers. Of the individual sub-themes identified participants most
frequently mentioned their discomfort with sharing their personal, sometimes traumatic, histories
with multiple providers (n = 6, 22.2%). As one participant shared, “Opening up about my past,
repeating myself over and over again to different counselors and psychologists, reopening the
wound, that was the worst.” Another participant similarly stated, “Explaining my situation to the
doctors and counselors over and over. This discourages me from wanting to go there.”
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Additional barrier categories included limited program availability (n = 4, 14.8%), and
anticipation of withdrawal symptoms (n = 4, 14.8%).
Lastly, given the limitations of some of the planned quantitative analyses, efforts were
made to identify information related to the original study variables. In particular, there was
variability in participants’ appraisal of their treatment experiences, such that four participants
expressed negative attitudes. Thus, these four cases were examined for potential response
patterns, particularly in their reports of treatment barriers. No patterns were detected. The rest of
the participants’ raw response data were examined for themes related to the independent and
dependent variables specified in Aims 1-3. Although treatment barriers and attitudes were
elicited by the questions, there did not appear to be enough variance in attitude valence to
identify a pattern of association; the remaining data did not appear comparable to the variables
specified in Aims 1-3.
Discussion
The present study was initiated with three overarching aims in mind. Aim 1 sought to
examine support preferences, treatment barriers, and attitudes toward treatment within a diverse
sample of pregnant and postpartum mothers who have endorsed substance use concerns. Aim 2
sought to examine associations of reported treatment barriers with help seeking preferences,
attitudes about treatment, treatment engagement, substance use, and life satisfaction. Aim 3 was
intended to assess cultural influences on the associations tested in aim 2. Additional efforts were
made to analyze qualitative interview responses in order to provide additional data to address
study and to detect unique information that may have been undetected by quantitative measures
and analyses.
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Although concerted efforts were made to recruit participants who had not had substance
use treatment experience, most participants responded to advertisements posted in substance use
treatment centers, potentially contributing to distributional concerns observed in some of the
measures (e.g., treatment engagement, help-seeking preferences). Nevertheless, although most
participants were treatment-experienced, the extent of their experience varied widely.
Furthermore, they reported substantial impact from a wide range of treatment barriers. A strength
of the study sample was that it was diverse in terms of ethnocultural and sociodemographic
representation.
Although this study was prepared to accommodate mono-lingual Spanish-speaking
participants, recruitment efforts did not yield participants from this population. Given that monolingual Spanish-speaking pregnant and postpartum women likely represent a small subset of the
overall population of pregnant and postpartum women, expecting that a smaller subset of this
population would endorse a substance use concern and elect to discuss it may have been
overambitious in hindsight. Nevertheless, approximately half of the recruited sample spoke a
second language (mostly Spanish). Furthermore, given the sample’s minority-majority
socioeconomic and ethnocultural characteristics, the majority of participants in this sample
represent perspectives that are underrepresented in the literature, particularly for this special
population.
The sample expressed generally positive attitudes toward all forms of mental health
support listed in The Help Seeking Preferences measure. This measure was intended to gauge
both treatment preferences and flexibility in support utilization. It is possible that the binary
response options placed undue limitations on the variance in participants responses.
Nevertheless, given that most participants had experience with substance use treatment, it is
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possible that the sample truly held such open and generally optimistic views of the utility of
different support sources. Qualitative data from participant interviews supported this possibility
in that most participants were able to generate positive statements about something they gained
from treatment. If results from this assessment are generalizable, it provides evidence in support
of other findings indicating that, rather than representing opposing approaches, the treatment and
support sources listed in this measure may frequently be endorsed together, such that people may
demonstrate somewhat bimodal distributions in their willingness to seek out support (Rüdell et
al., 2008)
The Attitudes Toward Professional Care measure yielded a more balanced distribution.
Participants indicated, on average, generally positive attitudes toward professional treatment.
Nevertheless, participants expressed a range of attitudes toward treatment, which included both
more negative and more positive views on either side of that mean score. Additional analyses
assessed for differences in attitudes on the basis of cultural variables, including ethnic identity,
second language fluency, and enculturation; yet cultural effects were not detected. It is possible
that the small sample size limited the power of these analyses. However, the literature has
reported highly variable response patters in terms of treatment attitudes and treatment
preferences on the basis of ethnicity, immigration status, and country location (e.g., Alvidrez &
Azocar, 1999; Nadeem et al., 2008). Thus while the field would benefit from more definitive
evidence on this topic, the results reported here are not necessarily in conflict with the extant
literature. Furthermore, it is possible that between-group differences in treatment attitudes and
preferences may be highly influenced by availability of and access to treatment. Of note, 96.2%
of this sample was insured, which is a larger percentage compared to reports from past U.S.
studies with comparable sample demographics and research aims (Nadeem et al., 2008). It is
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likely that changes in political climate and public policy impacts on treatment access will
continue to have noticeable impacts on the dynamics of treatment access, treatment utilization,
and attitudes toward professional treatment.
Despite the fact that most participants had experience with substance use treatment, the
sample still reported being highly impacted by stigma-related barriers in terms of treatment
engagement. In fact, participants rated stigma barriers as significantly more impactful compared
to instrumental barriers and all non-stigma barriers, collectively. Given that 81.5% of
participants met state and federal poverty guidelines and reported a number of instrumental
challenges in their qualitative interviews, the outcome that felt-stigma was rated as more
influential than instrumental barriers has strong implications for improving treatment
engagement in the community. For instance, ensuring that a clinic waiting room and
administrative staff are perceived as non-judgmental and inviting may be equally important to
ensuring other aspects of accessibility, such as transportation and insurance coverage. The
substantial impact of stigma demonstrated here supports other researchers’ assertions that
societal stigma directed toward mothers with substance use concerns is largely felt and
internalized by this specific population (Jacobs, 2014). Moreover, as expressed through
participants reports of these barriers, societal stigma directed toward this particular population is
counter-productive to their efforts toward treatment engagement and change.
Subsequent correlational analyses were intended to assess the strength of associations of
perceived treatment barriers with measures of help-seeking preferences, attitudes about
treatment, treatment engagement, substance use and life satisfaction. The analyses did not detect
significant effects for the hypothesized associations between these variables. It is possible that
the small sample size limited the power of these analyses to detect potential effects.
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Nevertheless, when acculturation and enculturation were entered into the analysis, significant
negative associations with past year drug use and family-related barriers to treatment emerged.
Although the substance use association was not further supported by the other substance use
measures assessed, the result supports the substantial literature indicating a protective impact of
enculturation on substance use behavior, particularly when acculturation is strongly endorsed as
well (e.g., Lopez-Tamayo et al., 2016; Yoon et al., 2013).
A final set of correlational analyses was conducted separately for White and non-White
participants to more thoroughly assess potential associations with the enculturation and
acculturation measures cultural, as well as detect potential unique effects based on ethnic
identity. Within the subsample of non-White participants, associations between enculturation and
acculturation with family-related treatment barriers were substantially strengthened, whereas the
same effects had diminished within the subsample of White participants. This seemed to
indicate that enculturation and acculturation scores from non-White participants were driving the
association when analyses were conducted for the sample as a whole. Within the subsample of
White participants, reports of fewer treatment barriers, especially instrumental and family-related
barriers, were strongly associated with participants’ lifetime substance use treatment
engagement. Although interpretations were made with caution for this subsample given its small
size, examination of a scatter plot seemed to indicate a strong linear relationship and the
associations were consistently significant across all barrier subscales. It was interesting, and
somewhat perplexing, that this association emerged for White participants alone. Nevertheless,
aside from ethnic differences, this finding fits with a substantial body of literature indicating that
women, and particularly mothers, are highly prone to be influenced by family when making
treatment decisions (e.g., Jessup et al., 2003; Mayer & Timms, 1970).
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Qualitative analyses allowed for additional supportive data as well as unique information
that was not detected through quantitative measures. It was a surprise to observe so few stigmarelated treatment barriers in response to a question that elicited many other treatment barriers.
This was somewhat inconsistent with participants’ reports on the BACE, which indicated a larger
effect from stigma relative to other treatment barriers. Given the observed inconsistency, it is
possible that instrumental variables were readily salient and easily generated in number, whereas
perhaps stigmatic barriers are more likely to demonstrate a strong effect when rated in terms of
their felt impact.
In general, responses to a question asking, “What about seeking treatment was difficult or
undesirable?” were consistent with many of the treatment barrier items assessed in the BACE.
However, two unique additional perspectives emerged through the interviews. In particular,
“fear” of withdrawal symptoms was indicated by several participants as an obstacle to their
treatment involvement. Second, a substantial number of participants described a common
experience of needing to retell their personal, sometimes trauma-related, histories to multiple
providers. Based on examination of the raw data, these experiences seemed to occur due to high
rates of clinician turnover, interdisciplinary patient care, or the structure of services offered by
the clinic. Given the frequency of such a specific and consistent response theme, it is reasonable
to expect that this experience may not be limited to the women in this study.
Limitations
Limitations in analysis options, power, and interpretations stemmed from the small
sample size. Additionally, the study would have benefited from a sample that was balanced with
participants uninvolved with treatment, as well as mono-lingual Spanish speaking participants as
originally intended. It is possible that similar barriers to those reported in this study are
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comparably impactful on this population’s ability or willingness to engage with research,
including anticipated perceptions of stigma and instrumental barriers including transportation,
childcare, and the monetary costs of these resources. In hindsight, some of these limitations may
have the potential to be addressed more effectively in future, similar studies given the lessons
learned through this one.
Strengths
Despite limitations, this study succeeded in recruiting a sample that was diverse in terms
of socio-economic factors and ethnic identity, thereby addressing a prominent gap in the
literature. Furthermore, despite the small sample, moderate to large effects were detected that
have meaningful implications for the treatment and emotional support needs of this population.
For instance, despite the small sample, a significant and stable effect of perceived stigma on
treatment engagement was detected. Lastly, qualitative analyses were unhindered by the small
sample and revealed additional treatment barriers that are likely unique to this special population.
Future Directions and Conclusions
The literature and healthcare community would benefit from further investigation into
ethnocultural impacts on stigma treatment barriers. Given records of disparities and
discrimination in healthcare (e.g., Thornicroft, 2008), it seems plausible that stigma may impact
different and overlapping populations at comparably high levels, but in qualitatively different
ways. Thus continued examination of both joint and discrete experiences of stigma is needed in
order to intervene.
Given that this was a challenging sample to recruit for in-person interviews, future
studies may benefit from cross-location collaboration using joint or comparable measures.
Alternatively, qualitative study designs and analytic approaches may be ideal solutions for

52

studying the target population. Ideally research and treatment communities will continue to
collaborate on efforts to identify and reduce barriers to mental health and substance use
treatment.
Although this study sample was limited in size, it gave voice to a collective experience of
stigma and its subjective impact on treatment engagement. Given that many to most participants
in this sample were single mothers below poverty cutoffs, the overall rating of stigma as more
impactful than instrumental barriers was noteworthy. Sadly, these findings support an
understanding that women with substance use issues are prone to experience heightened stigma
during a time of greater need and vulnerability. Nevertheless, the fact that participants most
frequently cited their children as primary motivations for seeking treatment indicates that this
may simultaneously be a time of prime opportunity for intervention.
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Figure 1. Hypothesized Model
Ethno-Cultural Identity
Attitudes about Professional Treatment
Treatment Engagement
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Figure 2. Participant Recruitment Process
Recruitment flyers distributed to 134+ sites
(in-person recruitment at 3)

41 people called

33 people screened

8 left messages and could
not be reached

30 screened eligible and were scheduled for
interviews

3 screened ineligible

27 completed interviews

3 no-showed and could not
be rescheduled
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Table 1. Recruitment Outreach and Participant Response by Source
Recruitment Source
1. WIC #1 Broadway
2. WIC #2 Candelaria
3. WIC #3 South Valley
4. WIC #4 Alamosa
5. ASAP
6. El Mesquite
7. Carneceria
8. Casa de Salud | Isleta & Arenal
9. 1st Choice Centro Familiar | Avenida & Bridge
10. Pro’s Ranch Market | Atrisco & Central
11. Clinica la Esperanza | Atrisco & Central
12. Downtown bus stops
13. Offices at 625 Silver Street
14. Heights park light poles
15. Downtown park light poles
16. South Valley park light poles
17. UNM Posting Board | SUB
18. UNM Posting Board | Duck Pond/ G-lot & Q-lot shuttle stop
19. UNM Posting Board | Woodward
20. UNM Posting Board | The Center of the Universe
21. UNM Posting Board | Regener Hall
22. Corner near Walmart San Mateo and Carlisle
23. SW bus stop San Mateo and Carlisle
24. Given to man at bus stop for his contacts
25. SE bust stop San Mateo and Carlisle
26. Bow and Arrow Lodge motel (Central)
27. Econo Lodge (Central)
28. Holiday Inn (Central)
29. Motel 6 (Central)
30. Rodeway Inn (Central)
31. Pinon motel (Central)
32. Unnamed motel San Mateo and Central
33. EZ Wash Laundromat (Central)
34. Red Door coffee shop/bar downtown
35. Train Station downtown
36. Under bridge near downtown train station
37. Ppl Plasma downtown
38. Emailed to Dr. Erika Johnson-Jimenez for doula contacts
39. Country Club Market | Coal Avenue & 10th street.
40. Barela’s Community Center | Rio Grande Zoo
41. Bus Stop | 8th St. & Stover
42. Wash Tub Laundromat |11th St. and Central
43. Mary Fox Park | Roma and 13th St.
44. Light Pole | Gold St. & 1st St.
45. Bus Stop | Gold St. and 6th St.
46. El Centro de Igualdad y Derechos | 4th St. & Hazeldine Ave.
47. NMILC building |Silver St. & 7th St.
48. Light Pole | Near First United Methodist Church
49. Hazeldine Park | Hazeldine Ave. & 3rd St.
50. Bus Stop | Broadway & Central Blvd.
51. Spin Cycle Laundromat |Atrisco and Central
52. West Mesa Market | Blue Water & 57th St.
53. YB Laundromat | Old Coors Dr. & Carlos Rey Circle
54. All Washed Up Laundromat | Old Coors Dr. & Sage Road
55. Laundromat | Paisano Center on Coors Blvd.
56. Wash Tub Laundromat | Rio Bravo & Isleta Blvd.
57. Division of Vocational Rehabilitation | Isleta Blvd. and Rio Bravo
58. Adobe Acres Laundromat | Isleta Blvd. & Camino Del Valle
59. Wash Brite Laundromat | Kathryn Ave. & San Pedro Dr.
60. The French Quarter Apartments | Paloma Dr. & Ross Ave.
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Participant Return (n)
1
1
21

1

61. Jack and Jill Park |San Pedro & Bell Ave.
62. Jeanne Bellamah Park | Tomasita St & Constitution Ave.
63. La Michoacana | Zuni & Arizona St.
64. Wilson Park | Anderson Ave. & Cardenas Dr.
65. CASAA waiting area
66. Coop Central and Carlisle
67. Brenda Frink, Brian Kimber, and Jackie West at Turquoise Lodge
68. Craigslist Albuquerque
69. Alibi online and print
70. Thai Vegan restauraunt
71. Milagro clinic SE Central
72. Milagro up north
73. Lovelace Grace Program
74. Milagro Tucker Ave
75. emailed to Ali, UNM medical student
76. El Centro Salvila
77. S. Valley Farmer’s Market Isleta
78. Expo NM Flea Market
79. Barrett House | Constitution & Eubank
80. Los Altos Park | Lomas & Eubank
81. Goodwill | Menaul & Juan Tabo
82. Spin Cycle Laundromat | Juan Tabo & Prospect Ave.
83. Sunrise Laundromat | Indian School and Tramway
84. Dollar Tree | Lomas & Morris Ave.
85. Rudy’s BBQ | Carlisle & I-40
86. Women’s Resource Center | UNM
87. UNM Posting Board | Old Education Building
88. Winning Coffee Café | Harvard & Central
89. Robinson Park | Central and 8th St.
90. Rudy’s BBQ | Coors & Alameda
91. Sudz Laundromat | 4th & Ranchitos Rd
92. Catholic Charities | Bridge & Pear Rd.
93. Spin Cycle Laundromat | 4th St & Guadalupe Trail
94. EZ Wash Laundromat | Griegos Rd & 4th St
95. Enlace Communitario | Yale & Alamo
96. Royal Car Wash | Central & Shirley St.
97. Bus Stop | Central & Wyoming
98. Tony Hillerman Public Library
99. Mesa Verde Community Center
100. Grace Thrift Store | Central & Utah
101. Mike’s Car Wash | Zuni and Rhode Island
102. Carniceria Chihuahua | Zuni and Charleston
103. Phil Chacon Park | Southern & Grove St.
104. Trumbull Park | Pennsylvania & Trumbull Ave.
105. Bus Stop | Front of Warren Sandia Apartments
106. Aspen Ridge Apartments | Louisiana & Continental Loop
107. Cesar E. Chavez Community Center | Kathryn Ave & Louisiana
108. Spin Cycle Laundromat | Louisiana & Central
109. Light pole | Lomas and Carlisle
110. Copy Center | Harvard and Silver Ave.
111. Bookcase Used Books | Cornell and Central
112. Highland Park | Elm & Silver Ave.
113. Light Pole | 4th and Central near alley
114. Light Pole | Central and High St.
115. UNM Posting Board | Outside Zimmerman Library
116. Women’s Specialists New Mexico | 1001 Coal Ave. Se.
117. Planned Parenthood | Eubank & Candeleria
118. Planned Parenthood | Lomas & Louisiana
119. Care Net Pregnancy Center | Eubank and Candeleria
120. Domestic Violence Resource Center | Silver & 7th
121. Goodwill | Juan Tabo & Constitution
122. 5 Points Indoor Market | Sunset and Bridge
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123. Light Pole | Near Pinon Motel & Apartments
124. Katie Avery (former contact), Maternal Health Program, DOH
125. emailed to Maureen Burns, Families First, DOH, 505-476-8911
126. emailed to Jessi Sanchez, Maternal Health Program, DOH
127. Zia Apartments
128. Other Mothers Thrift Store Montgomery
129. S Broadway Public Library
130. Planned Parenthood San Mateo & Marquette
131. Mental Health Fair
132. Medical Student Estefania Montanez
133. El Super S. Valley
134. Zia Family Focus Center
135. Word of mouth (Participant heard about study from friend, family, or other)
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Table 2. Demographic Characteristics
Female
Age
Ethnicity
Am. Indian/Al. Native
Black/African Am.
White
Hispanic
Multi-ethnic
Employment
Full time
Part time.
Homemaker
Unemployed
Language
English
English and Spanish
English and other
Education Years

n (%)
27 (100.0)

M (SD)
31.15 (4.89)

4 (14.8)
1 (03.7)
7 (25.9)
12 (44.4)
3 (11.1)
1 (03.7)
2 (07.4)
3 (11.1)
21 (77.8)
14 (51.9)
10 (37.0)
3 (11.1)
13.67 (3.80)
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Table 3. Independent and Dependent Variables
Mean
SD
Skewness
Kurtosis
Substance Use
DAST1 Past Year
4.93
4.23
-.138
-1.832
DAST1 Prior to Pregnancy
7.74
3.32
-1.588
1.306
AUDIT2 Past Year
6.81
10.42
1.687
2.022
AUDIT2 Prior to Pregnancy
9.52
12.22
1.236
.187
Days Since Last Use
191.52
248.17
1.298
.843
Barriers to Treatment
Barriers Total
57.93
25.04
-.493
-1.047
Barriers Stigma (raw)
22.15
10.54
-.380
-1.256
Barriers Non-Stigma (raw)
35.78
16.34
-.279
-1.191
Barriers Instrumental (raw)
8.11
4.11
-.683
-.573
Barriers Stigma (average)
1.70
.81
-.380
-1.256
Barriers Non-Stigma (average)
1.28
.58
-.279
-1.191
Barriers Instrumental (average)
1.35
.69
-.683
-.573
Cultural Identity
Acculturation
75.81
7.29
-1.246
1.749
Enculturation
67.19
16.74
-1.368
.994
Life Satisfaction
11.81
4.26
-.297
-.734
Attitudes toward Treatment
30.70
4.91
-.050
-.580
Help-Seeking Preferences
5.37
1.01
-2.066
4.522
Treatment Engagement (over 90 Days)
Outpatient Counseling for AUD/SUD
3.33
5.64
2.357
6.259
Outpatient Counseling for Other Concerns
1.00
3.15
3.269
10.106
Total In/Outpatient Treatment AUD/SUD
7.37
17.66
4.265
19.935
Total In/Outpatient Treatment Other
1.00
3.15
3.269
10.106
Opioid Maintenance Medication
37.00
42.45
.382
-1.885
Other Psychotropic Medication
27.89
40.00
.880
-1.181
Religious Attendance
2.11
3.85
2.041
3.074
Treatment Engagement (Lifetime)
Outpatient Counseling for AUD/SUD
115.48
187.37
2.729
7.199
Outpatient Counseling for Other Concerns
66.96
162.03
3.374
11.483
Total In/Outpatient Treatment AUD/SUD
132.59
196.31
2.311
4.981
Total In/Outpatient Treatment Other
67.11
162.48
3.380
11.537
Opioid Maintenance Medication
572.04
705.65
1.499
1.524
Other Psychotropic Medication
1558.22
2171.45
1.824
3.513
Note: N = 27, Skewness SE = .448, Kurtosis SE = .872. 1Drug Abuse Screening Test. 2Alcohol Use Disorder Screening Test.
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Table 4. Primary Drugs of Choice among Participants Endorsing Illicit Substance Use
n (%)
Endorsement of Past Year Use
17 (100.0)
Opiates, Opioids
11 (64.7)
Methamphetamine, Speed
4 (23.5)
Cocaine, Crack
2 (11.8)
Cannabis
0 (00.0)
Sedatives, Tranquilizers, Barbiturates
1 (17.6)
Endorsement of Year Prior to Pregnancy Use
24 (100.0)
Opiates, Opioids
21 (87.5)
Methamphetamine, Speed
9 (37.5)
Cocaine, Crack
0 (00.0)
Cannabis
4 (16.7)
Sedatives, Tranquilizers, Barbiturates
2 (08.3)
Note: Participants provided the above information following each DAST administration assessing two time frames. Drug
categories are not mutually exclusive as participants were able to report more than one substance.
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Table 5. Correlations between Independent and Dependent Variables
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
1 Barriers Total
2 B. Stigma
*.89
3 B. Non-Stig.
*.96
*.72
4 B. Inst.
*.82
*.61
*.85
5 B. Family
*.78
*.82
*.65
*.59
6 SUD Tx Total
-.32
-.34
-.27
-.21
-.27
7 SUD Therapy
.18
.05
.23
.23
-.08
.22
8 Other Therapy
.15
.22
.09
.16
.17
-.02
.17
9 SUD Meds
.02
-.15
.13
.16
-.10
*.41
*.48
.05
10 Other Meds
.33
.31
.31
.33
.11
-.12
.05
-.05
.15
11 Religion
.23
.27
.18
.04
.14
-.07
.11
.31
.08
-.08
12 Attitudes
-.12
-.05
-.16
-.25
-.26
.13
-.03
.09
.12
-.01
.33
13 Life Satisf.
.28
.19
.31
.35
.20
.15
-.02
.14
-.03
-.26
.26
.06
14 DAST
-.21
-.23
-.18
-.19
-.11
-.08
.36
.00
.16
-.05
-.13
.05
*-.40
15 DAST
-.06
-.20
.04
-.21
-.14
.16
.07
-.14
*.44
-.15
-.04
*.43
.08
.24
16 AUDIT
.15
.13
.14
.13
.13
-.02
*.39
-.08
.02
.19
-.08
-.17
-.29
.33
-.20
17 AUDIT
.06
.14
.00
.06
.12
-.12
.19
.15
.13
.32
.05
.02
-.32
*.38
-.07
*.78
18 Last Use
.05
.07
.03
-.00
.03
.14
-.22
-.25
-.11
-.16
-.07
.09
*.47
*-.61
.23
*-.42
*-.44
19 Acculturation
-.24
-.19
-.24
-.19
*-.40
-.00
-.20
-.09
-.07
.07
-.04
-.02
.11
*-.48
-.23
-.19
-.22
.36
20 Enculturation
-.18
-.13
-.20
-.18
*-.42
.05
-.18
.17
-.13
.04
.20
.18
.23
*-.48
-.14
-.27
-.20
.30
*.73
Note: *p < .05, *p < .01. 1) Treatment barriers total. 2) Stigma barriers. 3) Non-stigma barriers. 4) Instrumental barriers. 5) Family-related barriers. 6) All substance use treatment including counseling.
7) Substance use counseling. 8) Counseling for other psychological issues. 9) Opioid maintenance medication. 10) Other psychotropic medication. 11) Religious attendance. 12) Attitudes toward
Professional Help score. 13) Satisfaction with Life score. 14) Drug Abuse Screening Test, past year use. 15) Drug Abuse Screening Test, year prior to pregnancy use. 16) Alcohol Use Disorders
Screening Test, past year use. 17) Alcohol Use Disorders Screening Test, year prior to pregnancy use. 18) Days since last use at date of interview. All treatment engagement variables were within the
90-day time frame.
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Table 6. Cultural Differences in Support Utilization: Mann-Whitney Test Results
Between White and Non-White Participants
Opioid Maintenance Medication
Other Psychotropic Medication
Religious Attendance
Substance Use Counseling
Between Monolingual and Bilingual Participants
Opioid Maintenance Medication
Other Psychotropic Medication
Religious Attendance
Substance Use Counseling

Mann-Whitney U

Z

Sig.

55.5
66.0
44.5
60.5

-.884
-.258
-1.588
-.578

.431
.850
.162
.607

90.5
75.0
75.5
84.5

-.027
-.906
-.847
-.347

.981
.458
.458
.756
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Table 7. Correlations between Acculturation, Enculturation, Treatment Barriers, Treatment Engagement, and Substance Use
1
2
3
4
5
6
7
8
9
10
11
12
13
14
1 Enculturation
**.73
-.27
-.25
-.15
**-.66
.13
-.18
-.13
.07
-.41
-.19
-.17
-.15
2 Acculturation
.64
-.27
-.23
-.08
*-.56
.08
-.11
.04
.21
-.40
-.32
-.09
-.09
3 Barriers Total
.20
-.25
**.88
**.81
**.74
-.37
.18
.21
.24
-.13
.02
.15
.01
4 Barriers Stigma
.09
-.32
**.97
**.58
**.79
-.39
.05
.10
.14
-.11
-.11
.15
.09
5 Barriers Instrumental
-.06
-.54
**.91
**.88
*.56
-.29
.20
.15
.18
-.25
-.20
.07
-.05
6 Barriers Family-related
.08
-.17
**.88
**.90
*.84
-.30
.16
.25
.18
.07
.06
.18
.12
7 SUD Tx Total (90 days)
-.02
-.54
.24
.12
.31
-.09
.16
-.11
-.08
-.19
.13
-.07
-.17
8 SUD Therapy (90 days)
-.10
-.63
.20
.10
.30
-.13
**.99
.08
.13
.33
-.07
.41
.10
9 SUD Tx Total (Lifetime)
.02
.42
*-.79
*-.76
*-.84
*-.85
-.20
-.17
**.93
-.02
.20
.24
.18
10 SUD Therapy (Lifetime)
.31
.41
*-.78
-.75
*-.83
*-.83
-.22
-.18
**.99
-.13
.14
.22
.19
11 DAST past year
-.58
-.54
-.54
-.53
-.28
-.49
.44
.51
.14
.12
.25
.30
.37
12 DAST prior to pregnancy
.62
.18
-.27
-.40
-.30
-.53
.49
.47
.61
.60
.15
-.21
-.04
13 AUDIT past year
-.68
-.65
.43
.51
.50
.30
.26
.30
-.58
-.58
.06
-.61
**.79
14 AUDIT prior to pregnancy
-.64
**-.95
.35
.43
.55
.20
.55
.62
-.46
-.45
.40
-.27
*.82
Note: *p < .05, **p < .01. Statistics for White participants are located below the diagonal; statistics for non-White participants are located above the diagonal. 7,9) All substance use treatment including
counseling. 8,10) Substance use counseling. 11,12) Drug Abuse Screening Test. 13,14) Alcohol Use Disorders Screening Test.

77

Table 8. Coded Interview Responses
Frequency

(%)

14
6
3
3
2
1

51.9
22.2
11.1
11.1
7.4
3.7

8
7
3
3

30.8
25.9
11.1
11.1

3
2
2
2
1
1

11.1
7.4
7.7
7.4
3.7
3.7

13
3
3
3
2
2
2
1
1

48.1
11.1
11.1
11.1
7.4
7.4
7.4
3.7
3.7

Frequency

(%)

Favorable Aspects of Motherhood
Love special bond
Purpose
Child's development/watching them grow
Mom's development
Watching them be happy
All/general statement
Difficult Aspects of Motherhood
Lack of support
The attention/patience required
Financial cost
Self-doubt re mom skills
Sleep
Co-parenting
Communicating with child
Worrying about child safety
Learning how to be a mom
Watching them change
Factors Encouraging Treatment Engagement
Pregnancy/child's health
Self-determination
Something to occupy time
Mandated
Personal health
Family pressure/support
"Tired of it"
Religion spirituality
Housing security
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Group therapy
Everything else didn't work
Rapport w providers
Regain custody
Self-improvement
N/A no treatment experience
Perceived Treatment Benefits

1
1
1
1
1
3

3.7
3.7
3.7
3.7
3.7
11.1

Emotional fortitude/coping skills
Self-compassion
Nothing/don't know
Empowerment/self-efficacy
Normalization of challenges reduced sense of isolation
Help available
Social skills/healthy relationships
Regained functionality
Personal growth
Effects on child
Difficult Aspects of Treatment

9
5
4
3
2
2
2
1
1
1

33.3
18.5
14.8
11.1
7.4
7.4
7.4
3.7
3.7
3.7

6
3
1

22.2
11.1
3.7

3
2
2
2

11.1
7.4
7.4
7.4

4
3
Frequency

14.8
11.1
(%)

Emotional Barriers
Retelling of personal experiences to providers
Experiencing difficult emotion or stigma
Being told uncomfortable troths
Instrumental Barriers
Financial costs
Transportation/distance from clinic
Time cost
Insurance
Substance Use-Related
Withdrawal symptoms
Living without substance use

79

Program-Related
Limited treatment availability
Perceived ineffectiveness of program
Family

4
2
2

14.8
7.4
7.4
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